Correlation Between R S and Akums Drugs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both R S and Akums Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining R S and Akums Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between R S Software and Akums Drugs and, you can compare the effects of market volatilities on R S and Akums Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in R S with a short position of Akums Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of R S and Akums Drugs.

Diversification Opportunities for R S and Akums Drugs

0.86
  Correlation Coefficient

Very poor diversification

The 3 months correlation between RSSOFTWARE and Akums is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding R S Software and Akums Drugs and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akums Drugs and R S is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on R S Software are associated (or correlated) with Akums Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akums Drugs has no effect on the direction of R S i.e., R S and Akums Drugs go up and down completely randomly.

Pair Corralation between R S and Akums Drugs

Assuming the 90 days trading horizon R S Software is expected to under-perform the Akums Drugs. In addition to that, R S is 1.11 times more volatile than Akums Drugs and. It trades about -0.6 of its total potential returns per unit of risk. Akums Drugs and is currently generating about -0.17 per unit of volatility. If you would invest  61,870  in Akums Drugs and on December 2, 2024 and sell it today you would lose (16,320) from holding Akums Drugs and or give up 26.38% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

R S Software  vs.  Akums Drugs and

 Performance 
       Timeline  
R S Software 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days R S Software has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in April 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
Akums Drugs 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Akums Drugs and has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

R S and Akums Drugs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with R S and Akums Drugs

The main advantage of trading using opposite R S and Akums Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if R S position performs unexpectedly, Akums Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akums Drugs will offset losses from the drop in Akums Drugs' long position.
The idea behind R S Software and Akums Drugs and pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital